
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with Massdevice +3.
3. Jury trial begins in Medtronic/NuVasive patent spat


Opening arguments were heard yesterday in the jury trial of a patent infringement spat between Medtronic Inc. (NYSE:MDT) and NuVasive Inc. (NSDQ:NUVA) over spinal implant technology.
2. Will J&J recall breast implants under pressure?


Consumer groups demand that Johnson & Johnson’s (NYSE: JNJ) silicone breast implants be taken off the market because the company hasn’t followed the rules.
1. Stryker or Biomet to buy Smith & Nephew?


There’s renewed talk across the pond that Stryker Corp. (NYSE:SYK) is once again in the running to buy Smith & Nephew plc (NYSE:SNN), with one prominent U.K. analyst casting doubt on such a deal clearing U.S. anti-trust hurdles.